Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ferring Pharmaceuticals
Degarelix was not FDA regulated at the time of the trial. After completion of the trial degarelix has been approved by the FDA and is thus an FDA regulated intervention (FDA regulated intervention is therefore ticked "YES").
The data include participants from both the main study (FE200486 CS07; NCT00818623) and the extension study FE200486 CS07A.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Males aged 18 or over
Histologically proven adenocarcinoma of the prostate (all stages) in whom endocrine treatment was indicated (except neoadjuvant hormonal therapy)
Has completed Study FE200486 CS07
Has not met a withdrawal criteria at Visit 9 (day 28) in Study FE200486 CS07
